Lindenmayer JP - Search Results

1

A randomized controlled trial of cognitive remediation among inpatients with persistent mental illness.

Lindenmayer JP, McGurk SR, Mueser KT, Khan A, Wance D, Hoffman L, Wolfe R, Xie H. Lindenmayer JP, et al. Psychiatr Serv. 2008 Mar;59(3):241-7. doi: 10.1176/ps.2008.59.3.241. Psychiatr Serv. 2008. PMID: 18308903 Clinical Trial.

2

Improving social cognition in schizophrenia: a pilot intervention combining computerized social cognition training with cognitive remediation.

Lindenmayer JP, McGurk SR, Khan A, Kaushik S, Thanju A, Hoffman L, Valdez G, Wance D, Herrmann E. Lindenmayer JP, et al. Schizophr Bull. 2013 May;39(3):507-17. doi: 10.1093/schbul/sbs120. Epub 2012 Nov 3. Schizophr Bull. 2013. PMID: 23125396 Free PMC article. Clinical Trial.

3

COMT genotype and response to cognitive remediation in schizophrenia.

Lindenmayer JP, Khan A, Lachman H, McGurk SR, Goldring A, Thanju A, Kaushik S. Lindenmayer JP, et al. Schizophr Res. 2015 Oct;168(1-2):279-84. doi: 10.1016/j.schres.2015.07.037. Epub 2015 Aug 6. Schizophr Res. 2015. PMID: 26255563 Free PMC article. Clinical Trial.

4

Predictors of response to cognitive remediation in service recipients with severe mental illness.

Lindenmayer JP, Ozog VA, Khan A, Ljuri I, Fregenti S, McGurk SR. Lindenmayer JP, et al. Psychiatr Rehabil J. 2017 Mar;40(1):61-69. doi: 10.1037/prj0000252. Psychiatr Rehabil J. 2017. PMID: 28368180

5

The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficits.

Lindenmayer JP, Fregenti S, Kang G, Ozog V, Ljuri I, Khan A, Goldring A, McGurk SR. Lindenmayer JP, et al. Schizophr Res. 2017 Jul;185:154-160. doi: 10.1016/j.schres.2017.01.007. Epub 2017 Jan 13. Schizophr Res. 2017. PMID: 28094171

6

Outcome evaluation of a structured educational wellness program in patients with severe mental illness.

Lindenmayer JP, Khan A, Wance D, Maccabee N, Kaushik S, Kaushik S. Lindenmayer JP, et al. J Clin Psychiatry. 2009 Oct;70(10):1385-96. doi: 10.4088/JCP.08m04740yel. Epub 2009 Sep 22. J Clin Psychiatry. 2009. PMID: 19778494

7

Relationship between metabolic syndrome and cognition in patients with schizophrenia.

Lindenmayer JP, Khan A, Kaushik S, Thanju A, Praveen R, Hoffman L, Cherath L, Valdez G, Wance D. Lindenmayer JP, et al. Schizophr Res. 2012 Dec;142(1-3):171-6. doi: 10.1016/j.schres.2012.09.019. Epub 2012 Oct 26. Schizophr Res. 2012. PMID: 23106932

8

A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.

Lindenmayer JP, Khan A, Iskander A, Abad MT, Parker B. Lindenmayer JP, et al. J Clin Psychiatry. 2007 Mar;68(3):368-79. doi: 10.4088/jcp.v68n0303. J Clin Psychiatry. 2007. PMID: 17388705 Clinical Trial.

9

Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia.

Lindenmayer JP, Khan A. Lindenmayer JP, et al. Schizophr Res. 2011 Feb;125(2-3):267-77. doi: 10.1016/j.schres.2010.08.021. Epub 2010 Sep 17. Schizophr Res. 2011. PMID: 20850275 Clinical Trial.

10

Use of non-parametric item response theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS).

Khan A, Lewis C, Lindenmayer JP. Khan A, et al. Among authors: lindenmayer jp. BMC Psychiatry. 2011 Nov 16;11:178. doi: 10.1186/1471-244X-11-178. BMC Psychiatry. 2011. PMID: 22087503 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters